Billy Dunn
Impact in
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
Papers in ⓘ
-
- Stroke Rehabilitation and Recovery 2
- Co-authors
- Peter Stein (1 shared paper)Patrizia Cavazzoni (1 shared paper)Reisa A. Sperling (2 shared papers)Philip Scheltens (2 shared papers)Charlotte E. Teunissen (2 shared papers)Michael S. Rafii (1 shared paper)Clifford R. Jack (1 shared paper)Heather M. Snyder (1 shared paper)
- Journals
- Alzheimer s & Dementia (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Journal of Forensic Sciences (2 papers)Journal of Analytical Toxicology (2 papers)JAMA Internal Medicine (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Billy Dunn
20 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Psychiatry and Mental health 454
- Neurology 208
- Physiology 493
- Biological Psychiatry 46
- Health Informatics 17
Countries citing papers authored by Billy Dunn
This map shows the geographic impact of Billy Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Dunn more than expected).
Fields of papers citing papers by Billy Dunn
This network shows the impact of papers produced by Billy Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Dunn. The network helps show where Billy Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Billy Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Hit paper breakdown → | 2024 | 776 |
| 2 | Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective Hit paper breakdown → | 2021 | 174 |
| 3 | 2009 | 112 | |
| 4 | 2003 | 92 | |
| 5 | 2020 | 76 | |
| 6 | 2022 | 55 | |
| 7 | 2005 | 26 | |
| 8 | 1984 | 24 | |
| 9 | 2016 | 16 | |
| 10 | 1972 | 15 | |
| 11 | 2016 | 13 | |
| 12 | 1990 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2025 | 9 | |
| 15 | 1994 | 9 | |
| 16 | 2017 | 8 | |
| 17 | 2024 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2018 | 3 | |
| 20 | 2008 | 2 |
About Billy Dunn
Billy Dunn is a scholar working on Statistics and Probability, Rehabilitation, Toxicology, Geriatrics and Gerontology and Otorhinolaryngology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Alcohol Consumption and Health Effects (3 papers), Acute Ischemic Stroke Management (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Computational Drug Discovery Methods (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Stroke Rehabilitation and Recovery (2 papers). The work is most often cited by research in Psychiatry and Mental health (454 citations), Neurology (208 citations), Physiology (493 citations), Biological Psychiatry (46 citations) and Health Informatics (17 citations). Billy Dunn has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Peter Stein, Patrizia Cavazzoni, Reisa A. Sperling, Philip Scheltens, Charlotte E. Teunissen, Michael S. Rafii, Clifford R. Jack, Heather M. Snyder, J. Scott Andrews and Teresa Buracchio. Their work appears in journals such as Alzheimer s & Dementia, Clinical Pharmacology & Therapeutics, Journal of Forensic Sciences, Journal of Analytical Toxicology and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.